MAGGI, FABRIZIO
 Distribuzione geografica
Continente #
NA - Nord America 139
EU - Europa 103
AS - Asia 6
Totale 248
Nazione #
US - Stati Uniti d'America 138
IT - Italia 91
DE - Germania 3
ES - Italia 2
GB - Regno Unito 2
IN - India 2
SE - Svezia 2
CA - Canada 1
CN - Cina 1
DK - Danimarca 1
FR - Francia 1
HK - Hong Kong 1
PK - Pakistan 1
RU - Federazione Russa 1
TR - Turchia 1
Totale 248
Città #
Como 83
Fairfield 18
Santa Cruz 16
San Diego 9
Ashburn 8
Seattle 6
Chicago 5
Los Angeles 5
Cambridge 3
Lake Forest 3
Bengaluru 2
Buffalo 2
Houston 2
Lombard 2
San Francisco 2
Santa Clara 2
Woodbridge 2
Adana 1
Albany 1
Bedford 1
Bethesda 1
Büdelsdorf 1
Council Bluffs 1
Dallas 1
Denver 1
Fonthill 1
Frankfurt am Main 1
Henderson 1
Lleida 1
Lucca 1
Madrid 1
Milan 1
New Orleans 1
Pasadena 1
Portland 1
Rawalpindi 1
Reston 1
Rochester 1
Saint Petersburg 1
San Pablo 1
South Bend 1
Southampton 1
Stockholm 1
Turin 1
Varese 1
Vejle 1
Wilmington 1
Totale 200
Nome #
Redondovirus DNA in human respiratory samples, file e2188be7-8a35-4564-e053-6605fe0a49d6 37
Emergence of SARS-COV-2 Spike Protein Escape Mutation Q493R after Treatment for COVID-19, file e2188be7-d4f7-4564-e053-6605fe0a49d6 31
null, file e2188be8-0cf4-4564-e053-6605fe0a49d6 21
Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation, file e2188be8-225b-4564-e053-6605fe0a49d6 15
null, file e2188be7-f923-4564-e053-6605fe0a49d6 10
Anti-SARS-CoV-2 antibody levels and kinetics of vaccine response: potential role for unresolved inflammation following recovery from SARS-CoV-2 infection, file e2188be8-2326-4564-e053-6605fe0a49d6 10
Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021, file e2188be8-31b1-4564-e053-6605fe0a49d6 9
Viral infection neutralization tests: A focus on severe acute respiratory syndrome-coronavirus-2 with implications for convalescent plasma therapy, file e2188be7-8a3c-4564-e053-6605fe0a49d6 8
TTV GUIDE IT - A randomised controlled trial to compare the safety, tolerability and preliminary efficacy between standard and torque teno virus-guided immunosuppression in stable adult kidney transplant recipients with low immunological risk in the first year after transplantation - a trial protocol, file e2188be8-1224-4564-e053-6605fe0a49d6 8
Crispr/cas9 ablation of integrated hiv-1 accumulates proviral dna circles with reformed long terminal repeats, file e2188be8-0f50-4564-e053-6605fe0a49d6 7
Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence, file e2188be8-2c2c-4564-e053-6605fe0a49d6 7
null, file e2188be8-38f3-4564-e053-6605fe0a49d6 7
SARS-CoV-2 detection in primary thyroid sarcoma: coincidence or interaction?, file e2188be8-0c95-4564-e053-6605fe0a49d6 6
Introduction of SARS-COV-2 C.37 (WHO VOI lambda) from Peru to Italy, file e2188be7-d484-4564-e053-6605fe0a49d6 5
How multiplex testing approach to respiratory viruses detection can enhance influenza surveillance, file e2188be7-f22a-4564-e053-6605fe0a49d6 5
Hyaluronan: A neuroimmune modulator in the microbiota-gut axis, file e2188be8-13c7-4564-e053-6605fe0a49d6 5
Role of Low-Molecular-Weight Heparin in Hospitalized Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia: A Prospective Observational Study, file e2188be8-2d51-4564-e053-6605fe0a49d6 5
Delivery Mode Shapes the Composition of the Lower Airways Microbiota in Newborns, file e2188be8-2f32-4564-e053-6605fe0a49d6 5
Breakthrough Infections of E484K-Harboring SARS-CoV-2 Delta Variant, Lombardy, Italy, file e2188be7-e3b2-4564-e053-6605fe0a49d6 4
Performance Assessment of the LIAISON® SARS-CoV-2 Antigen Assay On Nasopharyngeal Swabs, file e2188be8-11eb-4564-e053-6605fe0a49d6 4
Modified Hemagglutination Tests for COVID-19 Serology in Resource-Poor Settings: Ready for Prime-Time?, file e2188be8-2827-4564-e053-6605fe0a49d6 4
Sotrovimab-emergent resistance in SARS-CoV-2 Omicron: A series of three cases, file 495e0c38-934d-47c4-838b-b5b4fe661fa2 3
COVID-19 and smoking: Is nicotine the hidden link?, file e2188be7-8a37-4564-e053-6605fe0a49d6 3
Assessment of automated high-throughput serological assays for prediction of high-titer SARS-CoV-2 neutralizing antibody, file e2188be7-cfba-4564-e053-6605fe0a49d6 3
Characterization of a Lineage C.36 SARS-CoV-2 Isolate with Reduced Susceptibility to Neutralization Circulating in Lombardy, Italy, file e2188be7-d0d8-4564-e053-6605fe0a49d6 3
Microbiome in Chronic Obstructive Pulmonary Disease: Role of Natural Products Against Microbial Pathogens, file e2188be7-8425-4564-e053-6605fe0a49d6 2
Taxonomic updates for the genus Gyrovirus (family Anelloviridae): recognition of several new members and establishment of species demarcation criteria, file e2188be8-0e71-4564-e053-6605fe0a49d6 2
Taxonomic update for mammalian anelloviruses (family Anelloviridae), file e2188be8-0f58-4564-e053-6605fe0a49d6 2
Filovirus, file e2188be7-842c-4564-e053-6605fe0a49d6 1
Filovirus, file e2188be7-8435-4564-e053-6605fe0a49d6 1
COVID-19 emergency management: From the reorganization of the endoscopy service to the verification of the reprocessing efficacy, file e2188be7-8a33-4564-e053-6605fe0a49d6 1
Nicotine Changes Airway Epithelial Phenotype and May Increase the SARS-COV-2 Infection Severity, file e2188be7-8bc8-4564-e053-6605fe0a49d6 1
Exploring the Relevance of Senotherapeutics for the Current SARS-CoV-2 Emergency and Similar Future Global Health Threats, file e2188be7-9145-4564-e053-6605fe0a49d6 1
Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline, file e2188be7-9438-4564-e053-6605fe0a49d6 1
Impact of Microbial Metabolites on Microbiota–Gut–Brain Ax-is in Inflammatory Bowel Disease, file e2188be7-cb31-4564-e053-6605fe0a49d6 1
Imported SARS-COV-2 Variant P.1 Detected in Traveler Returning from Brazil to Italy, file e2188be7-cbdf-4564-e053-6605fe0a49d6 1
Previous humoral immunity to the endemic seasonal alphacoronaviruses NL63 and 229E is associated with worse clinical outcome in COVID-19 and suggests original antigenic sin, file e2188be7-cc1c-4564-e053-6605fe0a49d6 1
SARS-CoV-2 B.1.1.7 reinfection after previous COVID-19 in two immunocompetent Italian patients, file e2188be7-cd88-4564-e053-6605fe0a49d6 1
Anti-SARS-CoV-2 RBD IgG responses in convalescent versus naïve BNT162b2 vaccine recipients, file e2188be7-cd8b-4564-e053-6605fe0a49d6 1
Introduction of SARS-CoV-2 variant of concern 20h/501Y.V2 (B.1.351) from Malawi to Italy, file e2188be7-cd8d-4564-e053-6605fe0a49d6 1
Is a single COVID-19 vaccine dose enough in convalescents ?, file e2188be7-ce66-4564-e053-6605fe0a49d6 1
Nicotine upregulates ACE2 expression and increases competence for SARS-CoV-2 in human pneumocytes, file e2188be7-cfbb-4564-e053-6605fe0a49d6 1
Lack of neutralizing activity in nonconvalescent sera, regardless of ABO blood group and anti-A isoagglutinin titer, file e2188be7-d13f-4564-e053-6605fe0a49d6 1
SYMPTOMATIC SARS-CoV-2 INFECTIONS AFTER FULL SCHEDULE BNT162b2 VACCINATION IN SEROPOSITIVE HEALTHCARE WORKERS: A CASE SERIES FROM A SINGLE INSTITUTION, file e2188be7-d4ab-4564-e053-6605fe0a49d6 1
Circulating SARS-CoV-2 variants in Italy, October 2020-March 2021, file e2188be7-d826-4564-e053-6605fe0a49d6 1
SPIKE PROTEIN EVOLUTION IN THE SARS-CoV-2 DELTA VARIANT OF CONCERN: A CASE SERIES FROM NORTHERN LOMBARDY, file e2188be7-edaf-4564-e053-6605fe0a49d6 1
Analysis of immune escape variants from antibody‐based therapeutics against covid‐19: A systematic review, file e2188be8-0f52-4564-e053-6605fe0a49d6 1
Molecular validation of pathogen-reduction technologies using rolling-circle amplification coupled with real-time PCR for torquetenovirus DNA quantification, file e2188be8-0f56-4564-e053-6605fe0a49d6 1
COVID-19 infodemics: the role of mainstream and social media, file e2188be8-1071-4564-e053-6605fe0a49d6 1
Spike mutations in SARS-CoV-2 AY sublineages of the Delta variant of concern: implications for the future of the pandemic, file e2188be8-2c2e-4564-e053-6605fe0a49d6 1
Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: A prospective observational study, file e2188be8-2c34-4564-e053-6605fe0a49d6 1
Is SARS-CoV-2 viral clearance in nasopharyngeal swabs an appropriate surrogate marker for clinical efficacy of neutralising antibody-based therapeutics?, file e2188be8-2d4f-4564-e053-6605fe0a49d6 1
Very low levels of remdesivir resistance in SARS-COV-2 genomes after 18 months of massive usage during the COVID19 pandemic: A GISAID exploratory analysis, file e2188be8-2f30-4564-e053-6605fe0a49d6 1
MS-based targeted profiling of oxylipins in COVID-19: A new insight into inflammation regulation, file e2188be8-328b-4564-e053-6605fe0a49d6 1
Totale 257
Categoria #
all - tutte 879
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 879


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0000 00 02 2000
2021/2022170 0006 916 2415 1839349
2022/202383 1338284 00 00 0000
Totale 257